By Scott Meacham Copyright © 2019, The Oklahoman At i2E, we like to invest in life sciences companies. About 40 percent of our portfolio is in therapeutics, diagnostics and medical devices. We recognize the abundant opportunity for these types of startups in Oklahoma, and we have developed the staff, expertise and partnerships to commercialize technologiesRead more